AKR1B1 and Hepatic fibrosis: Interestingly, our earlier metabolomic investigation of patients with chronic hepatitis C revealed a clear induction of the aldose reductase AKR1B10 with enhanced catabolism of both glucose and galactose [18], although the stage of hepatic fibrosis in these patients was not reported.